Clinical Biochemistry Practice Questions

Q: Alpha-1 antitrypsin is synthesized in which organ?

Liver. **Explanation:** **Alpha-1 Antitrypsin (AAT)** is a glycoprotein belonging to the **serpin** (serine protease inhibitor) superfamily. Its primary physiological role is to inhibit **neutrophil elastase**, an enzyme that breaks down elastin in the alveolar walls of the lungs. 1. **Why Liver is Correct:** The **liver** (specifically hepatocytes) is the primary site of synthesis for AAT. Once synthesized, it is secreted into the systemic circulation to reach the lungs. In AAT deficiency (specifically the PiZZ phenotype), a genetic mutation causes the protein to misfold and aggregate within the endoplasmic reticulum of hepatocytes, leading to liver cirrhosis and decreased serum levels. 2. **Why Other Options are Incorrect:** * **Brain:** While the brain produces specific neurotrophic factors and proteins, it does not synthesize systemic protease inhibitors like AAT. * **Spleen:** The spleen is primarily involved in lymphoid filtration and RBC sequestration; it is not a major site for plasma protein synthesis. * **Kidney:** The kidney filters small proteins but does not synthesize AAT. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** AAT protects the lungs from **panacinar emphysema** by neutralizing neutrophil elastase. * **Genetics:** Encoded by the **SERPINA1 gene** on Chromosome 14. * **Clinical Presentation:** AAT deficiency presents with a "double hit"—**Liver Cirrhosis** (due to protein accumulation) and **Early-onset Emphysema** (due to lack of alveolar protection, especially in smokers). * **Histology:** PAS-positive, diastase-resistant globules in hepatocytes are pathognomonic for AAT deficiency. * **Acute Phase Reactant:** AAT levels rise during inflammation.

Q: The Hemoglobin A1c level indicates the patient's level of glycemic control during which time period?

2-3 months. **Explanation:** **The Underlying Concept:** Hemoglobin A1c (HbA1c), or glycated hemoglobin, is formed by the non-enzymatic, irreversible attachment of glucose to the N-terminal valine of the beta chain of hemoglobin. This process is called **glycation**. Because this attachment is permanent for the life of the red blood cell (RBC), the HbA1c level reflects the average blood glucose concentration over the lifespan of the erythrocyte. The average lifespan of an RBC is approximately **120 days (4 months)**; however, the HbA1c level is weighted more heavily toward the most recent 8–12 weeks because older cells are constantly being cleared. Therefore, it clinically represents glycemic control over the preceding **2–3 months**. **Analysis of Options:** * **A (1-2 months):** Too short. While recent glucose levels impact the value more, the RBC survival extends beyond this period. * **B (2-3 months):** **Correct.** This aligns with the physiological turnover of RBCs and the weighted average of glucose exposure. * **C & D (3-5 months):** Too long. Although some RBCs live up to 120 days, the steady-state turnover means the pool of hemoglobin reflects a shorter average window. **High-Yield Clinical Pearls for NEET-PG:** * **Falsely Low HbA1c:** Seen in conditions with increased RBC turnover (e.g., Hemolytic anemia, recent blood transfusion, treatment for iron/B12 deficiency, pregnancy). * **Falsely High HbA1c:** Seen in conditions with decreased RBC turnover (e.g., Iron deficiency anemia, Splenectomy). * **Diagnostic Thresholds:** Normal: <5.7%; Pre-diabetes: 5.7–6.4%; Diabetes Mellitus: **≥6.5%**. * **Fructosamine Test:** Measures glycated albumin; reflects glycemic control over the past **2–3 weeks** (useful when HbA1c is unreliable).

Q: Urine urobilinogen is absent in which of the following conditions?

Obstructive jaundice. ### Explanation The presence or absence of urine urobilinogen depends on the **enterohepatic circulation of bilirubin**. **1. Why Obstructive Jaundice is correct:** In complete obstructive (post-hepatic) jaundice, there is a physical blockage of the bile duct (e.g., gallstones or carcinoma head of pancreas). This prevents conjugated bilirubin from entering the intestine. Since intestinal bacteria cannot act on bilirubin to convert it into **urobilinogen**, no urobilinogen is formed or reabsorbed into the blood. Consequently, none is excreted by the kidneys, making urine urobilinogen **absent**. **2. Why other options are incorrect:** * **Viral Hepatitis (Hepatocellular Jaundice):** There is partial interference with bilirubin excretion, but some still reaches the gut. Furthermore, the damaged liver cannot efficiently reabsorb the urobilinogen returning from the gut, leading to **increased** urine urobilinogen levels. * **Hemolytic Jaundice:** Excessive breakdown of RBCs leads to increased production of unconjugated bilirubin, which results in high amounts of urobilinogen being formed in the gut. This leads to **markedly increased** urine urobilinogen. **Clinical Pearls for NEET-PG:** * **Urine Bilirubin:** Only **conjugated** bilirubin appears in urine (it is water-soluble). It is present in obstructive and hepatocellular jaundice but **absent** in hemolytic jaundice (acholuric jaundice). * **Stool Color:** In obstructive jaundice, the absence of stercobilin (derived from urobilinogen) leads to **clay-colored stools**. * **Van den Bergh Reaction:** * Indirect positive: Hemolytic Jaundice. * Direct positive: Obstructive Jaundice. * Biphasic: Hepatocellular Jaundice.

Q: What is the most sensitive marker of cardiac injury?

Troponin. **Explanation:** **Troponins (specifically Cardiac Troponin I and T)** are considered the **most sensitive and specific markers** for myocardial injury. They are structural proteins of the cardiac myofibril. Troponin I is exclusively found in the heart, making it highly specific. Their high sensitivity allows for the detection of even minute areas of myocardial necrosis (micro-infarction) that other markers might miss. They begin to rise 3–6 hours after injury and remain elevated for 7–14 days, providing a wide diagnostic window. **Analysis of Incorrect Options:** * **A. LDH (Lactate Dehydrogenase):** This is a non-specific marker found in many tissues (liver, RBCs, muscle). While LDH-1/LDH-2 "flip" was used historically, it rises late (24–48 hours) and is now obsolete in acute settings. * **B. Myoglobin:** This is the **earliest marker** to rise (within 1–3 hours) because it is a small, cytosolic protein. However, it is **not specific** to the heart as it is also released during skeletal muscle injury. * **C. CPK-MB:** Formerly the "gold standard," it is specific to the heart but less sensitive than Troponins. Its main clinical utility today is detecting **re-infarction**, as it returns to baseline quickly (within 48–72 hours). **High-Yield Clinical Pearls for NEET-PG:** * **Earliest Marker:** Myoglobin. * **Most Specific/Sensitive Marker:** Cardiac Troponin I. * **Marker for Re-infarction:** CK-MB. * **Troponin T vs. I:** Troponin T can be elevated in renal failure; Troponin I is more cardiac-specific. * **BNP (Brain Natriuretic Peptide):** Used for the diagnosis and prognosis of Heart Failure, not acute injury.

Q: Alkaline phosphatase is found in all organs, except?

Heart. **Explanation:** Alkaline Phosphatase (ALP) is a group of isoenzymes that hydrolyze phosphate esters at an alkaline pH. It is primarily associated with tissues involved in high metabolic activity or transport across membranes. **Why Heart is the correct answer:** ALP is notably **absent or present in negligible amounts in the Heart**. The primary enzymes found in cardiac tissue are Creatine Kinase (CK-MB), Aspartate Aminotransferase (AST), and Lactate Dehydrogenase (LDH). Therefore, ALP is not used as a biomarker for myocardial injury. **Analysis of Incorrect Options:** * **Bone (Option A):** ALP is highly concentrated in **osteoblasts**. It is a marker of bone formation and is elevated in conditions like Paget’s disease, rickets, and bone metastases. * **Placenta (Option C):** The placenta produces a heat-stable isoenzyme of ALP. It rises during the third trimester of pregnancy. (Note: The **Regan isoenzyme** is a placental-like ALP seen in some cancers). * **Lungs (Option D):** ALP is present in the vascular endothelium and alveolar cells of the lungs. While not a primary diagnostic source, it is physiologically present. **High-Yield Clinical Pearls for NEET-PG:** 1. **Major Sources:** The mnemonic **"L-B-P"** (Liver, Bone, Placenta) helps remember the primary sites. The Liver (biliary canaliculi) and Bone are the most clinically significant sources. 2. **Heat Stability Test:** To differentiate sources, remember: *"Placenta is Stable, Bone is Blown"* (Placental ALP is heat-stable at 65°C; Bone ALP is heat-labile at 56°C). 3. **Intestinal ALP:** Found in individuals with blood groups B or O, especially after a fatty meal. 4. **Clinical Marker:** ALP is the most sensitive marker for **obstructive jaundice** (cholestasis) and space-occupying lesions in the liver.

Q: Alkaline phosphatase (ALP) is not found in which of the following?

Red blood cells. **Explanation:** Alkaline phosphatase (ALP) is a group of isoenzymes that catalyze the hydrolysis of organic phosphate esters at an alkaline pH. It is primarily a membrane-bound enzyme found in tissues associated with high metabolic activity or transport processes. **Why Red Blood Cells (RBCs) is the correct answer:** RBCs do not contain alkaline phosphatase. Instead, the characteristic phosphatase found in RBCs is **Acid Phosphatase (ACP)**. This distinction is clinically significant; while ALP levels are used to monitor bone and liver diseases, they are unaffected by hemolysis, unlike enzymes like LDH or Potassium which are abundant in RBCs. **Analysis of Incorrect Options:** * **Liver:** ALP is located on the canalicular membranes of hepatocytes. It is a sensitive marker for **cholestasis** (obstructive jaundice), where its synthesis increases in response to bile duct obstruction. * **Bone:** ALP is produced by **osteoblasts** and is essential for bone mineralization. Elevated levels are seen in high bone turnover states like Paget’s disease, rickets, and hyperparathyroidism. * **Prostate:** While the prostate is famously associated with Acid Phosphatase (PSA/PAP), it does contain small amounts of ALP. However, compared to RBCs (which have zero ALP), the prostate is not the correct choice for "not found." **High-Yield Clinical Pearls for NEET-PG:** 1. **Sources of ALP (Mnemonic: BLIP):** **B**one (Osteoblasts), **L**iver (Canalicular), **I**ntestine, and **P**lacenta (Regan Isoenzyme). 2. **Heat Stability:** The placental isoenzyme is the most heat-stable ("**P**lacenta is **P**ersistent"), while the bone isoenzyme is the most heat-labile ("**B**one is **B**urnable"). 3. **Zinc Dependency:** ALP is a **zinc-containing metalloenzyme**; deficiency of zinc can lead to low ALP levels. 4. **Clinical Marker:** ALP is the most sensitive enzyme for detecting space-occupying lesions (SOLs) in the liver.

Q: Which of the following is a marker of new bone formation?

Alkaline phosphatase. ### Explanation **Correct Option: A. Alkaline Phosphatase (ALP)** Bone formation is a process mediated by **osteoblasts**. During this process, osteoblasts secrete the bone-specific isoenzyme of **Alkaline Phosphatase (BAP)**. ALP plays a crucial role in mineralization by increasing the local concentration of inorganic phosphate and neutralizing pyrophosphate (a mineralization inhibitor). Therefore, elevated serum levels of ALP (specifically the bone-specific fraction) serve as a primary biochemical marker of osteoblastic activity and new bone formation. **Analysis of Incorrect Options:** * **B. Acid Phosphatase:** Specifically, Tartrate-Resistant Acid Phosphatase (TRAP) is a marker of **bone resorption**. It is secreted by **osteoclasts** during the breakdown of the bone matrix. * **C. Hydroxyproline:** This is an amino acid found in collagen. When bone collagen is degraded, hydroxyproline is released into the blood and excreted in the urine. Thus, it is a marker of **bone resorption**, not formation. **High-Yield Clinical Pearls for NEET-PG:** * **Markers of Bone Formation (Osteoblastic activity):** 1. Bone-specific Alkaline Phosphatase (BAP) - *Most commonly tested.* 2. Osteocalcin (Bone Gla protein). 3. Serum Procollagen type 1 N-terminal propeptide (**P1NP**) - *Considered the most sensitive marker for monitoring osteoporosis treatment.* * **Markers of Bone Resorption (Osteoclastic activity):** 1. Urinary/Serum **NTX** (N-telopeptide) and **CTX** (C-telopeptide) of type 1 collagen. 2. Tartrate-Resistant Acid Phosphatase (TRAP 5b). 3. Urinary Hydroxyproline and Pyridinoline. * **Clinical Note:** In **Paget’s disease**, ALP is characteristically very high, while calcium and phosphate levels typically remain normal.

Q: Adenosine deaminase levels in CSF are significantly higher in which condition?

Tuberculous meningitis. ### **Explanation** **Adenosine Deaminase (ADA)** is an enzyme involved in purine metabolism, specifically the conversion of adenosine to inosine. It is primarily found in T-lymphocytes, and its activity increases during the proliferation and differentiation of T-cells in response to intracellular pathogens. **1. Why Tuberculous Meningitis (TBM) is correct:** TBM is characterized by a **cell-mediated immune response** involving the activation of T-lymphocytes. When *Mycobacterium tuberculosis* infects the meninges, T-cells release ADA into the cerebrospinal fluid (CSF). A CSF-ADA level **>10 U/L** is a highly sensitive and specific biomarker for TBM, making it a crucial rapid diagnostic tool while waiting for culture results. **2. Why the other options are incorrect:** * **Bacterial Meningitis:** This condition is dominated by a **neutrophilic** response rather than a T-lymphocyte response. While ADA may be slightly elevated, it rarely reaches the high diagnostic thresholds seen in TBM. * **Viral Meningitis:** This typically presents with a lymphocytic pleocytosis, but the degree of T-cell activation and subsequent ADA release is significantly lower than in mycobacterial infections. * **Syphilitic Meningitis:** While chronic, it does not typically produce the high levels of ADA associated with the intense granulomatous inflammation of TBM. **3. High-Yield Clinical Pearls for NEET-PG:** * **Cut-off value:** CSF-ADA **>10 U/L** is strongly suggestive of TBM. * **Other fluids:** ADA is also used to diagnose **Tubercular Pleural Effusion** (cut-off >40 U/L) and **Tubercular Ascites**. * **Differential:** High ADA can also be seen in CNS Lymphoma and Neurobrucellosis, but in the context of the NEET-PG, TBM is the primary association. * **ADA Deficiency:** Leads to **Severe Combined Immunodeficiency (SCID)** due to the accumulation of toxic dATP, which inhibits DNA synthesis in lymphocytes.

Q: What is the normal serum bilirubin level?

0.1-0.5 mg/dl. **Explanation:** The correct answer is **C (0.1-0.5 mg/dl)**. In clinical biochemistry, serum bilirubin is measured as Total, Direct (conjugated), and Indirect (unconjugated) bilirubin. While the **Total Serum Bilirubin** typically ranges from **0.2 to 1.2 mg/dl**, this specific question focuses on the **Direct (Conjugated) Bilirubin** fraction, which normally stays below **0.5 mg/dl**. In many standard textbooks and laboratory references used for NEET-PG, the normal range for direct bilirubin is specifically cited as 0.1–0.4 or 0.1–0.5 mg/dl. **Analysis of Options:** * **Option A (0.3-1.2 mg/dl):** This represents the normal range for *Total Bilirubin*. While clinically significant, it does not match the specific value provided in the key for this question. * **Option B & D (2-4 mg/dl and 1-2 mg/dl):** These values are elevated. Clinical jaundice (icterus) becomes visible to the naked eye only when total serum bilirubin exceeds **2.0–2.5 mg/dl**. **High-Yield Clinical Pearls for NEET-PG:** 1. **Van den Bergh Reaction:** This is the gold standard for bilirubin estimation. Direct bilirubin reacts *immediately* (Direct Positive), while indirect bilirubin requires the addition of alcohol to react (Indirect Positive). 2. **Latent Jaundice:** A state where serum bilirubin is elevated (above 1.2 mg/dl) but remains below the threshold for clinical visibility (2.0 mg/dl). 3. **Hyperbilirubinemia:** Unconjugated hyperbilirubinemia is seen in hemolytic anemias and Crigler-Najjar syndrome, whereas conjugated hyperbilirubinemia suggests biliary obstruction or Dubin-Johnson syndrome.

Q: What is the time frame over which HbA1c reflects glycemic control?

6-8 weeks. **Explanation:** **1. Why Option C is Correct:** HbA1c (Glycated Hemoglobin) is formed by the non-enzymatic, irreversible attachment of glucose to the N-terminal valine of the beta chain of hemoglobin. Since erythrocytes (RBCs) have an average lifespan of **120 days**, HbA1c serves as a weighted average of blood glucose levels over the preceding **2 to 3 months (8–12 weeks)**. However, in the context of NEET-PG and standard biochemistry textbooks (like Harper’s or Vasudevan), the most significant contribution to the HbA1c value comes from the preceding **6–8 weeks**, making it the most accurate clinical reflection of medium-to-long-term glycemic control. **2. Why Other Options are Incorrect:** * **A & B (2–6 weeks):** These timeframes are too short for HbA1c. These durations are more characteristic of **Fructosamine** (glycated albumin) levels, which reflect control over the past 2–3 weeks due to the shorter half-life of albumin. * **D (14–18 weeks):** This exceeds the average 120-day (17-week) lifespan of an RBC. By this time, the majority of the glycated RBCs have been cleared from circulation by the spleen. **3. High-Yield Clinical Pearls for NEET-PG:** * **The "Weighted" Effect:** 50% of the HbA1c value is determined by the glucose levels of the preceding 30 days. * **False Lows:** HbA1c is falsely low in conditions with high RBC turnover (e.g., Hemolytic anemia, recent blood loss, or Pregnancy). * **False Highs:** HbA1c is falsely high in Iron Deficiency Anemia (due to increased RBC longevity) and Splenectomy. * **Diagnostic Cut-off:** According to ADA criteria, an HbA1c **≥ 6.5%** is diagnostic for Diabetes Mellitus.

Question 1

Alpha-1 antitrypsin is synthesized in which organ?

Accepted Answer

Liver

Answer

Brain

Answer

Spleen

Answer

Kidney

Question 2

The Hemoglobin A1c level indicates the patient's level of glycemic control during which time period?

Accepted Answer

2-3 months

Answer

1-2 months

Answer

3-4 months

Answer

4-5 months

Question 3

Urine urobilinogen is absent in which of the following conditions?

Accepted Answer

Obstructive jaundice

Answer

Viral hepatitis

Answer

Hemolytic jaundice

Answer

All of the above

Question 4

What is the most sensitive marker of cardiac injury?

Accepted Answer

Troponin

Answer

LDH

Answer

Myoglobin

Answer

CPK-MB

Question 5

Alkaline phosphatase is found in all organs, except?

Accepted Answer

Heart

Answer

Bone

Answer

Placenta

Answer

Lungs

Question 6

Alkaline phosphatase (ALP) is not found in which of the following?

Accepted Answer

Red blood cells

Answer

Liver

Answer

Bone

Answer

Prostate

Question 7

Which of the following is a marker of new bone formation?

Accepted Answer

Alkaline phosphatase

Answer

Acid phosphatase

Answer

Hydroxyproline

Answer

None of the above

Question 8

Adenosine deaminase levels in CSF are significantly higher in which condition?

Accepted Answer

Tuberculous meningitis

Answer

Bacterial meningitis

Answer

Viral meningitis

Answer

Syphilitic meningitis

Question 9

What is the normal serum bilirubin level?

Accepted Answer

0.1-0.5 mg/dl

Answer

0.3-1.2 mg/dl

Answer

2-4 mg/dl

Answer

1-2 mg/dl

Question 10

What is the time frame over which HbA1c reflects glycemic control?

Accepted Answer

6-8 weeks

Answer

2-3 weeks

Answer

3-6 weeks

Answer

14-18 weeks

Clinical Biochemistry — MCQs

Clinical Biochemistry — MCQs

On this page

Practice by Chapter

Want unlimited practice?